At the J.P. Morgan Healthcare Conference 2026, the Alliance will convene another strategic panel, From Products to Patients: Capturing Value in Asia's Growth Markets, bringing together Gilead Sciences' SVP of Emerging Markets, the head of U.S. DFC's global health investments, and the CEOs of reach52 and Nivi, Inc. to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia. A post-JPM panel reception will follow, offering a continuation of the conversation and networking opportunities from 4:30-6:30pm PT.